These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36866739)

  • 1. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.
    Cai T; Zhang C; Zhan T
    Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36866739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy.
    Meng C; Yang Y; Feng W; Ma P; Bai R
    J Orthop Surg Res; 2023 Nov; 18(1):892. PubMed ID: 37993925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal transfer of MDR by exosomes in human osteosarcoma.
    Torreggiani E; Roncuzzi L; Perut F; Zini N; Baldini N
    Int J Oncol; 2016 Jul; 49(1):189-96. PubMed ID: 27176642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-resistant osteosarcoma cell-derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801-dependent manner.
    Pan Y; Lin Y; Mi C
    Cell Biol Int; 2021 Apr; 45(4):858-868. PubMed ID: 33325136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma.
    Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z
    Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy.
    Tian W; Niu X; Feng F; Wang X; Wang J; Yao W; Zhang P
    Biomed Pharmacother; 2023 Jul; 163():114771. PubMed ID: 37119740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
    Zhu KP; Zhang CL
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells.
    Zhou X; Natino D; Zhai X; Gao Z; He X
    Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma.
    Ren X; Su C
    Mol Med Rep; 2020 Sep; 22(3):2183-2190. PubMed ID: 32705189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
    Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
    Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
    Zhang Y; Duan G; Feng S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
    Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
    Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z
    Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis.
    Bai Y; Li Y; Bai J; Zhang Y
    J Orthop Surg Res; 2021 Aug; 16(1):510. PubMed ID: 34407841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR-524/RASSF6 axis.
    Zhou W; Liu Y; Wu X
    J Gene Med; 2021 Oct; 23(10):e3373. PubMed ID: 34151476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.
    Wu C; Li Z; Feng G; Wang L; Xie J; Jin Y; Wang L; Liu S
    Bioengineered; 2021 Dec; 12(1):8378-8395. PubMed ID: 34592889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.
    Hu Y; Gu J; Shen H; Shao T; Li S; Wang W; Yu Z
    J Clin Lab Anal; 2020 Feb; 34(2):e23045. PubMed ID: 31642110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of multidrug‑resistant osteosarcoma sublines and the molecular mechanisms of resistance.
    Yang JZ; Ma SR; Rong XL; Zhu MJ; Ji QY; Meng LJ; Gao YY; Yang YD; Wang Y
    Mol Med Rep; 2016 Oct; 14(4):3269-76. PubMed ID: 27498972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.